Skip to content

Jazz Pharmaceuticals JAZZ United Kingdom — United kingdom and united states

Discontinued — last reported Q4 '24

Similar metrics at other companies

Revvity logo
RVTYUNITED KINGDOM — Segment revenue
$31.71M+12.4%
SEI Investments logo
SEICUnited Kingdom — Total Revenue
$43.94M+14.6%
FCF
FCFSU.K. — Revenue
$37.67M
Broadridge Financial Solutions logo
BRUNITED KINGDOM — Revenue
$116.18M+4.2%
Crown Holdings logo
CCKUnited Kingdom — Revenue recognized
$93M-6.5%
PEA
PEAKUK — Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept jazz:DeferredForeignIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 26, 2025, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's united kingdom — united kingdom and united states.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's united kingdom — united kingdom and united states?
Jazz Pharmaceuticals (JAZZ) reported united kingdom — united kingdom and united states of $0 in Q4 2024.
How has Jazz Pharmaceuticals's united kingdom — united kingdom and united states changed year-over-year?
Jazz Pharmaceuticals's united kingdom — united kingdom and united states decreased by 100.0% year-over-year, from $67K to $0.
What is the long-term trend for Jazz Pharmaceuticals's united kingdom — united kingdom and united states?
Over 3 years (2021 to 2024), Jazz Pharmaceuticals's united kingdom — united kingdom and united states has grown at a -100.0% compound annual growth rate (CAGR), from $259.87M to $0.
What does united kingdom — united kingdom and united states mean?
The net profit or loss generated by the company's business operations located in the United Kingdom.
How do you interpret united kingdom — united kingdom and united states?
An increase indicates improved profitability or reduced costs within the UK market, while a decrease suggests declining sales, higher operational expenses, or potential restructuring charges.
How does united kingdom — united kingdom and united states compare across companies?
Comparable to regional segment operating income reported by other multinational biopharmaceutical companies with significant international footprints.